ArQule Message Board - Msg: 1788559

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ArQule

ARQL 20.00

0.0%

Jan 16 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (83)	7/18/1997 2:27:00 AM
From: scaram(o)uche	of 399

Good question. Theoretically, money can accomodate productive growth. But, you need to hire the right mid-level managers. Cetus is a good example of what can happen to a company if they blow it at this level. Incyte seems to have been successful at managing explosive growth. I'd say that it depends on Hogan's capacities as a manager. There are enough good chemists to fit the projects. What's required is finding good talent and making sure that projects are compartmentalized. If Hogan and Gordon can't do this, then ArQule also has cash flow that can derive from mediocre "first there" jobs. However, it's the directed-array and lead optimization projects that are part of the partnerships that will pay the bigest bucks and sustain this level of growth. Maybe they need you, Miljenko?? :-) Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next